Drugs Made In America Acquisition II Stock (NASDAQ:DMII)
Previous Close
$10.16
52W Range
$9.86 - $10.21
50D Avg
$10.12
200D Avg
$10.02
Market Cap
$647.37M
Avg Vol (3M)
$74.25K
Beta
0.04
Div Yield
-
DMII Company Profile
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.